reactive amyloidosis exhibits features of a prion disease. Aggregate fibrils consisting of serum amyloid A, a protein whose overexpression in humans and other animals can lead to reactive amyloidosis, are capable of recruiting soluble serum amyloid A in a process that appears to spread the amyloid throughout the organism (Johan et al., 1998) .
Further study of functional amyloid and prions will undoubtedly provide insights into the etiology of amyloid and prion diseases by educating us about the means by which biological systems can harness amyloid and prions without deleterious effects from the aggregates. A significant achievement in this effort would be the development of a general method to characterize amyloid and prions in different organisms solely based on their structural and functional attributes without regard to their sequences. In combining a computational approach with a variety of functional assays to identify numerous new prion sequences, the work of Alberti et al. has brought us one step closer to this goal.
Adipose tissue is central to the control of energy homeostasis. Although white adipose tissue acts primarily as a site of fat storage, it also communicates with peripheral and central sites in times of excess or insufficient food supply through the release and action of a variety of adipokines, including adiponectin and leptin (Dahlman and Arner, 2007) . In contrast, brown adipose tissue protects against obesity through the action of β-adrenergic stimulation and thyroid hormone in regulating adaptive thermogenesis due to mitochondrial uncoupling (Cannon and Nedergaard, 2004) . Brown adipose tissue has a high density of mitochondria and elevated oxidative capacity. Brown fat also expresses uncoupling protein 1 (UCP1), which plays a pivotal role in adaptive thermogenesis by uncoupling the mitochondrial protein gradient from ATP production. PPARγ coactivator-1α (PGC-1α) is a key coordinator of gene regulatory responses that promote mitochondrial biogenesis and thermogenic programs in brown adipose tissue, as well as in skeletal muscle. PGC-1α carries out these functions through its interaction with members of the nuclear receptor family of proteins, including peroxisome proliferator-activated receptor δ (PPARδ) (Puigserver et al., 1998) . In this issue, Pan et al. (2009) show that twist-1 is a negative feedback regulator of PGC-1α/PPARδ-mediated brown fat metabolism. This regulation controls mitochondrial metabolism and uncoupling and has implications for energy homeostasis in obesity (Figure 1 ).
Twist-1 is a highly conserved transcription factor that belongs to the basic helix-loop-helix (bHLH) family of proteins (Thisse et al., 1987) . It acts as a regulator of various processes including early development, apoptosis, cancer, and osteoblast differentiation (Sosic and Olson, 2003) . In humans, a germline mutation in the coding sequence of twist-1, which results in haploinsufficiency, is respon- The transcriptional coactivator PGC-1α promotes mitochondrial biogenesis and thermogenic programs in brown adipose tissue. Pan et al. (2009) identify the transcription factor twist-1 as a negative feedback regulator of PGC-1α.
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Cell 137, April 3, 2009 ©2009 Elsevier Inc. 23 sible for Saethre-Chotzen syndrome, a disorder characterized by limb abnormalities, asymmetry of the head and face, and premature fusion of cranial sutures (Pantke et al., 1975) . Despite the detailed understanding of the role of twist-1 in early development and cancer, little is known concerning its function in metabolism.
Pan et al. screen human and mouse gene expression databases for transcriptional regulators and discover that twist-1 is preferentially expressed in adipose tissue. They perform quantitative PCR analysis and confirm that twist-1 is abundantly expressed in white and brown adipose tissue from adult mice, as well as in mature adipocytes, compared to cultured preadipocytes in vitro. Interestingly, lipid accumulation in differentiated brown adipocytes and adipogenic differentiation in mouse 3T3L1 cells (a white adipocyte cell line) is unaltered by twist-1 overexpression, indicating that this transcriptional regulator does not participate in lipid formation or adipogenesis. Additional cellular and physiological approaches reveal that twist-1 regulates PGC-1α-controlled oxidative metabolism and uncoupling in brown adipose tissue, thereby uncovering a new regulatory network that is exclusively involved in energy dissipation.
At the cellular level, the inhibition of PGC-1α transcriptional activity by twist-1 does not involve a decrease in PGC-1α protein or altered PGC-1α localization, but rather depends on an interaction between the N-terminal region of twist-1 and the C-terminal region of PGC-1α. Twist-1 is recruited by PGC-1α to the promoters of PGC-1α target genes and blocks their induction. The functional consequence of this is to reduce cellular oxygen consumption and fatty acid oxidation. Hence, the predicted physiological outcome of twist-1 overexpression in vivo is the development of obesity. Conversely, knockdown of twist-1 in brown adipocytes using small interfering RNAs (siRNAs) increases expression of PGC-1α target genes, including UCP1, and promotes mitochondrial biogenesis. Knockdown of PGC-1α using RNA interference prevents these effects. From these experiments, it would be predicted that diminished twist-1 expression would result in resistance to obesity. Collectively, these studies provide evidence that twist-1 targets PGC-1α to modulate cellular oxygen consumption by regulating mitochondrial oxidative metabolism in brown adipocytes.
The physiological role of twist-1 has important implications for the regulation of whole-body energy homeostasis. Pan et al. show that transgenic mice overexpressing twist-1 in adipose tissue have a normal phenotype when fed normal chow. However, when placed on a highfat diet, these mice display enhanced weight gain compared to wild-type mice without altering food intake. In these mice, expression of UCP1, fatty acid oxidation genes, oxygen consumption, and mitochondrial density are decreased, whereas lipid accumulation is increased in brown adipose tissue but not white adipose tissue. Although physical activity, whole-body oxygen consumption, respiratory exchange ratio, or absolute body weight was not determined, body temperature tends to be lower in the twist-1 transgenic mice. Conversely, twist-1 heterozygous mice are protected against dietary-induced obesity. Expression of UCP1 and fatty acid oxidation genes, oxygen consumption, and mitochondrial density are increased, whereas lipid accumulation is decreased in brown adipose but not white adipose tissue. Interestingly, PGC-1α expression is unaltered by twist-1 overexpression or knockout, indicating that twist-1 influences cellular and whole-body energy homeostasis by modulating PGC-1α transcriptional activity in brown adipose tissue. Indeed, PGC-1α recruits twist-1 to specific PGC-1α-target gene promoters, which causes a decrease in histone H3 acetylation, possibly due to recruitment of histone deacetylase 5 (HDAC5).
Evidence is emerging that PPARδ activation induces expression of genes required for fatty acid oxidation and energy dissipation to improve lipid profiles and prevent obesity (Wang et al., 2003) . Interestingly, overexpression of either PPARδ (Wang et al., 2003) or PGC-1α (Puigserver et al., 1998) The interaction between twist-1, the transcriptional coactivator PGC-1α, and the nuclear receptor PPARδ controls expression of PGC-1α target genes to promote mitochondrial biogenesis and energy dissipation. Pan et al. (2009) show that the level of twist-1 protein controls gene expression, cellular adaptations, and whole-body physiological responses to changes in nutrient availability. They establish that twist-1 orchestrates a brown fat-specific regulatory network that controls energy dissipation.
to be required for endogenous twist-1 expression. Nevertheless, further evidence is presented for a feedback loop between PPARδ and twist-1: PPARδ, but not PPARα or PPARγ, bind to the twist-1 promoter and direct twist-1 expression in brown adipocytes. Given that PPARδ acts as a lipid sensor, these findings raise the possibility that nutrients may influence this transcriptional network. Additionally, energy sensors such as the AMP-activated protein kinase (AMPK) may lie upstream of PPARδ. AMPK activators increase expression of PGC-1α target genes, and siRNAs against either PPARδ or AMPK subunits block the effects of PPARδ agonists on fatty acid oxidation (Kramer et al., 2007) . However, any requirement for AMPK signaling in the PPARδ-inducible, negative feedback loop of twist-1 on PGC-1α transcriptional regulation is speculative.
Given the unexpected evidence for brown adipose tissue in humans (Nedergaard et al., 2007) , the role of twist-1 in mitochondrial biogenesis and thermogenic programs in brown adipose tissue may have important implications for human obesity. Bearing in mind that the physiological role of brown fat in adult humans remains unclear, do alterations in the twist-1 protein level influence PGC1-α-dependent gene expression and metabolism in humans? Evidence from clinical genetics implicates twist-1 haploinsufficiency in Saethre-Chotzen syndrome. Hence, caution should be exercised when considering pharmacological approaches to target twist-1 expression in humans. Furthermore, the role of twist-1 in other tissues expressing PPARδ and PGC1-α, such as cardiac and oxidative skeletal muscle, should be considered to fully appreciate whether twist-1 has a role beyond that described for brown adipose tissue. The identification of twist-1 as a regulator of programs in brown adipose tissue reveals new insight into the mechanisms controlling cellular and whole-body energy homeostasis in obesity.
There is an old story about five blind men who are presented with an elephant and asked to identify what is before them. Each touches only a portion of the animal, and offer guesses ranging from a rope to a tree branch. It is likely that the men would have done better had they first practiced on another large animal, such as a camel, knowing a priori what was before them. In that way, they could have benchmarked their approaches, that is, assessed their relative performances using a common standard.
There is much interest in both systems biology, that is, the use of integrated experimental and computational approaches for studying endogenous biomolecular networks, and synthetic biology, that is, the use of engineering techniques to model, design, and construct artificial biomolecular networks.
One of the cornerstones of systems biology research is the identification of network structures from experimental data through reverse engineering (inference) approaches. In many ways, those of us working in this area are like the five blind men confronted with an elephant-we are not sure what the actual biomolecular networks look like, and we lack accurate benchmarks for our reverse-engineering approaches.
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